Genetic Variant Linked to Nerve-related Side Effects from Childhood ALL Treatment

A genome-wide association study published today in the Journal of the American Medical Association describes a regulatory variant that appears to dial up the risk of adverse outcomes in children with acute lymphoblastic leukemia who are treated with the anti-cancer drug vincristine.

Read more here: https://www.genomeweb.com/cancer/genetic-variant-linked-nerve-related-side-effects-childhood-all-treatment